Zurcher Kantonalbank (Zurich Cantonalbank) Amylyx Pharmaceuticals, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $30.1 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024
SELL
$2.71 - $19.57 $994 - $7,182
-367 Reduced 3.53%
10,022 $28,000
Q4 2023

Jan 30, 2024
BUY
$12.07 - $18.46 $51,357 - $78,547
4,255 Added 69.37%
10,389 $152,000
Q3 2023

Oct 25, 2023
BUY
$18.08 - $23.45 $15,530 - $20,143
859 Added 16.28%
6,134 $112,000
Q2 2023

Aug 07, 2023
BUY
$20.98 - $31.42 $96,256 - $144,154
4,588 Added 667.83%
5,275 $113,000
Q1 2023

May 08, 2023
BUY
$27.71 - $40.93 $19,036 - $28,118
687 New
687 $20,000

Others Institutions Holding AMLX

# of Institutions
139
Shares Held
46.5M
Call Options Held
226K
Put Options Held
909K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email